Clearance for Glaxo's influenza drug in US
The Food and Drug Administration allowed Glaxo Wellcome to sell Relenza, its new influenza drug, in the US - reversing the recommendation by an FDA expert committee in February. The UK company
The Food and Drug Administration allowed Glaxo Wellcome to sell Relenza, its new influenza drug, in the US - reversing the recommendation by an FDA expert committee in February. The UK company